Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk

AIMS: Ticagrelor is associated with a lower risk of ischemic events than clopidogrel. However, it is uncertain whether the benefits of more intensive anti-ischemic therapy outweigh the risks of major bleeding in patients who have a high bleeding risk (HBR). Therefore, this study compared ticagrelor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjerkaski, Jonathan, Jernberg, Tomas, Alfredsson, Joakim, Erlinge, David, James, Stefan, Lindahl, Bertil, Mohammad, Moman Aladdin, Omerovic, Elmir, Venetsanos, Dimitrios, Szummer, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627816/
https://www.ncbi.nlm.nih.gov/pubmed/37263787
http://dx.doi.org/10.1093/ehjcvp/pvad041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627816/
https://www.ncbi.nlm.nih.gov/pubmed/37263787
http://dx.doi.org/10.1093/ehjcvp/pvad041

Ejemplares similares